Tsuyoshi Kiyota

Title: The Innovative Contributions of Tsuyoshi Kiyota in Pharmaceutical Composition

Introduction

Tsuyoshi Kiyota, an accomplished inventor based in Tokyo, Japan, has made significant strides in the pharmaceutical industry with his intellectual contributions. He holds one patent that showcases his ingenuity in formulating effective drug compositions.

Latest Patents

Kiyota’s notable patent addresses the formulation of a pharmaceutical composition containing mirabegron. This innovation aims to provide a modified release liquid suspension that contains mirabegron, offering several advantages. The composition is designed to be ready-to-suspend and solves the challenge of undissolved lumps that can occur when the product is reconstituted before use. Specifically, Kiyota's invention involves a complex of mirabegron or a pharmaceutically acceptable salt thereof combined with sodium polystyrene sulfonate, enhancing the medication's usability and effectiveness.

Career Highlights

Kiyota is associated with Astellas Pharma GmbH, a company known for its commitment to innovation in healthcare. His role within the organization emphasizes his expertise in pharmaceutical research and development, contributing to advancements that could improve patient outcomes.

Collaborations

Throughout his career, Kiyota has collaborated with talented professionals in the field, including Seiji Takae and Toshiro Sakai. Together, they work towards enhancing medical technology and expanding the potential of pharmaceutical compositions.

Conclusion

In summary, Tsuyoshi Kiyota stands out as a significant inventor in the realm of pharmaceutical innovation. His work, particularly involving mirabegron, has the potential to impact the industry positively, reflecting his dedication to improving medicinal formulations. His contributions, along with those of his collaborators, underscore the importance of teamwork in fostering innovation in the pharmaceutical sector.